EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrated lipidomic and proteomic profiling reveals metabolic network disruption by SARS-CoV-2 variants

Scotland E Farley, Jennifer E Kyle, Helene Jahn, Lisa M Bramer, Paul D Piehowski, Athena A Shepmoes, Brooke Ld Kaiser, Sarai M Williams, Josie G Eder, Carsten Schultz, Fikadu G Tafesse

Journal of Lipid Research · 2025-08 · 66 (8) · 100860

DOI: 10.1016/j.jlr.2025.100860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2025-08. Verfasst von Scotland E Farley und 10 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health & Science University, Department of Molecular Microbiology and Immunology, Portland, OR; Oregon Health & Science University, Department…. Hauptthemen laut MEDLINE: Lipidomics, SARS-CoV-2, Proteomics, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIH NIGMS, U.S. Department of Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid evolution of SARS-CoV-2 has produced myriad viral strains with increasing transmissibility and capacity for immune evasion. While effective vaccination campaigns have reduced the fatalities associated with SARS-CoV-2, infections continue, and a detailed understanding of how this virus manipulates host biochemical pathways remains elusive. We asked both whether the patterns of host lipid rewiring remained consistent across variants and whether the changes in the abundance of lipid classes are related to changes in the expression of the enzymes involved in their biosynthesis. We compared global nontargeted lipidomics on A549-ACE2 cells infected with the delta variant (B.1.617.2), or the omicron (B.1.1.529) variant to our previous results of global nontargeted lipidomics on A549-ACE2 cells infected with the original WA1 strain and further performed quantitative proteomics to assess changes in the host proteome. We found that metabolic rewiring, both on the lipid and the enzymatic level, is remarkably consistent across all three variants. We further mapped changes in the expression of host metabolic enzymes, linking enzyme expression to alterations in the abundance of specific lipids during infection. This analysis identified key proteins related to virus-mediated changes in lipid abundance, including fatty acid synthase (FASN), lysosomal acid lipase (LIPA), and ORMDL, a regulator of sphingolipid biosynthesis. These integrated lipidomic and proteomic experiments shed light on the importance of the complex network of host metabolism networks that support SARS-CoV-2 infection and suggest that lipid metabolism may be a promising avenue for uncovering conserved therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipidomicsSARS-CoV-2ProteomicsCOVID-19Metabolic Networks and PathwaysProteomeHumansA549 CellsLipid Metabolism

Stichwörter der Autor:innen

SARS-CoV-2SARS-CoV-2 variantsceramidescoronavirushost-virus interactionlipid metabolismlipidomicsneutral lipidsproteomicssphingolipids

Substanzen

Proteome

Autor:innen und Institutionen

  • Oregon Health & Science University, Department of Molecular Microbiology and Immunology, Portland, OR; Oregon Health & Science University, Department of Chemical Physiology and Biochemistry, Portland, OR.
  • Oregon Health & Science University, Department of Molecular Microbiology and Immunology, Portland, OR; Pacific Northwest National Laboratories (PNNL), Biological Sciences Division, Earth and Biological Sciences Director…
  • Pacific Northwest National Laboratories (PNNL), Computational Biology Group, Earth and Biological Sciences Directorate, Richland, WA.
  • Pacific Northwest National Laboratories (PNNL), Biological Sciences Division, Earth and Biological Sciences Directorate, Richland, WA.
  • Oregon Health & Science University, Department of Chemical Physiology and Biochemistry, Portland, OR.
  • Oregon Health & Science University, Department of Molecular Microbiology and Immunology, Portland, OR; Oregon Health & Science University, Department of Chemical Physiology and Biochemistry, Portland, OR. Electronic add…

Förderung

  • NIGMS NIH HHS
  • NIH NIGMS
  • U.S. Department of Energy
  • National Institutes of Health
  • Laboratory Directed Research and Development
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research
  • Pacific Northwest National Laboratory

Zitieren

APA

Farley, S. E., Kyle, J. E., Jahn, H., Bramer, L. M., Piehowski, P. D., Shepmoes, A. A., Kaiser, B. L., Williams, S. M., Eder, J. G., Schultz, C., & Tafesse, F. G. (2025). Integrated lipidomic and proteomic profiling reveals metabolic network disruption by SARS-CoV-2 variants. Journal of Lipid Research, 66(8), 100860. https://doi.org/10.1016/j.jlr.2025.100860

Vancouver

Farley SE, Kyle JE, Jahn H, Bramer LM, Piehowski PD, Shepmoes AA, et al. Integrated lipidomic and proteomic profiling reveals metabolic network disruption by SARS-CoV-2 variants. Journal of Lipid Research. 2025;66(8):100860. doi:10.1016/j.jlr.2025.100860

BibTeX
@article{Farley2025,
  author = {Farley, Scotland E and Kyle, Jennifer E and Jahn, Helene and Bramer, Lisa M and Piehowski, Paul D and Shepmoes, Athena A and Kaiser, Brooke Ld and Williams, Sarai M and Eder, Josie G and Schultz, Carsten and Tafesse, Fikadu G},
  title = {Integrated lipidomic and proteomic profiling reveals metabolic network disruption by SARS-CoV-2 variants},
  journal = {Journal of Lipid Research},
  year = {2025},
  volume = {66},
  number = {8},
  pages = {100860},
  doi = {10.1016/j.jlr.2025.100860}
}
Kostenlos starten →